Medical News

RSS

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.

21 Aug 2009

URAC extends support to develop and standardize health care quality improvement measures

URAC, the nation's leading healthcare accreditation and education organization, announced today that it has joined the more than 180 organizations supporting Stand for Quality. Stand for Quality is made up of organizations including AARP, the American Medical Association, National Consumers League, and the U.S. Chamber of Commerce that represent every segment of the health care industry.

21 Aug 2009

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

...

21 Aug 2009

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

...

21 Aug 2009

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

Thursday's state news includes concerns over Medicaid reimbursement cuts in Colorado, the opening of the Utah Health Exchange amidst skyrocketing premiums and the high number of uninsured in Texas.

21 Aug 2009

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone.

21 Aug 2009

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

CEL-SCI Corporation. (NYSE Amex: CVM), a biotechnology company entering a late stage oncology trial and focused on infectious disease, today announced that it has entered into a definitive agreement with several institutional investors to sell 9.7 million units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $4.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.

21 Aug 2009

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.

21 Aug 2009

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

21 Aug 2009

Interfix receives AHDI Integrity Award for Innovation Through Technology

InterFix LLC is the 2009 recipient of the AHDI Integrity Award for Innovation Through Technology for the release of its BenchMark KB™ Knowledge Base product in 2008. The Integrity Awards focus on contributions made by individuals and corporations that align with the Association’s focus on integrity. The awards are designed to highlight innovative thinking and best practices that the Association believes will drive the clinical documentation sector in the coming years.

21 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, from Eli Lilly Canada Inc. Takeda, the discoverer of ACTOS, licensed the drug to Lilly as part of a worldwide agreement in 1999.

21 Aug 2009

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

More than 1 million Kenyans living in prolonged drought conditions are not getting the food aid they need, Gabrielle Menezes, a spokeswoman for the U.N.'s World Food Program (WFP), said recently, the Associated Press reports. She said WFP already provides emergency food aid to about 2.5 million people in Kenya, but another 1.3 million still need help.

21 Aug 2009

Sound Inpatient Physicians and Obama discuss on health care reform

Brett Kronenberger, M.D., a Chief Hospitalist of Sound Inpatient Physicians, and a group of community leaders held a private meeting with President Barack Obama prior to the Town Hall meeting on health care reform, in Belgrade, Montana last Friday.

21 Aug 2009

Synthes to distribute ECM products manufactured by Kensey Nash following a strategic agreement

Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.

21 Aug 2009

Syntagon to deliver presentation on controlling genotoxic impurities

Leading contract research organisation, Syntagon, is to deliver a presentation on controlling genotoxic impurities at one of the Pharma industry’s highest profile events, CPhI Worldwide, being held this October in Madrid, Spain.

21 Aug 2009

UFCW opposes Whole Foods CEO John Mackey's efforts to undermine meaningful health care reform

In response to a recent Wall Street Journal op-ed by Whole Foods’ Chief Executive Officer John Mackey, activists, consumers and labor groups around the country have been organizing in opposition to his efforts to undermine meaningful health care reform.

21 Aug 2009

The American Hospital Association endorses the EXTENSION Healthid smart card system

The American Hospital Association, through its subsidiary, AHA Solutions, Inc., has announced its exclusive endorsement of EXTENSION® HealthID™. HealthID™ is a secure smart card that holds individual patient data for use by the hospitals to improve the care experience. Hospitals are able to quickly find and use patient’s information within an individual facility or across their system or network. The benefits of the smart card include providing much improved patient experiences and streamlined administrative costs.

21 Aug 2009

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.

21 Aug 2009

Rxi Pharmaceuticals to recruit a new Chief Financial Officer

RXi Pharmaceuticals Corporation today announced that Stephen J. DiPalma, has resigned as Executive Vice President of Business Operations and Chief Financial Officer to pursue other opportunities, effective August 28, 2009.

21 Aug 2009

Medical News

MedAssurant announces certification of event rate outcomes for HIP Medicare Advantage patients

URAC extends support to develop and standardize health care quality improvement measures

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

HCCA's Research Compliance Conference to address Compliance Issues in International Clinical Trials

State round-up: Colorado's medicaid woes, Utah's Health Exchange, and more

HeartWare achieves enrollment milestone under its ADVANCE Clinical Trial in the U.S

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

Inc. magazine ranks Signature Genomic Laboratories no.1012 on its fastest-growing private companies ranking list

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Interfix receives AHDI Integrity Award for Innovation Through Technology

Cannabis chemicals stop prostate cancer growth

Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug

WFP says more than 1M Kenyans need food aid due to drought; India increases food distribution to deal with drought

Sound Inpatient Physicians and Obama discuss on health care reform

Synthes to distribute ECM products manufactured by Kensey Nash following a strategic agreement

Syntagon to deliver presentation on controlling genotoxic impurities

UFCW opposes Whole Foods CEO John Mackey's efforts to undermine meaningful health care reform

The American Hospital Association endorses the EXTENSION Healthid smart card system

Plextronics finalizes $14 Million financing to fund its research, development and pilot manufacturing programs

Rxi Pharmaceuticals to recruit a new Chief Financial Officer

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News